News & Updates

Original New Drug Application Approvals by US FDA (1-15 April 2024)

26 Apr 2024

New drug applications approved by US FDA as of 1-15 April 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 April 2024)

26 Apr 2024

Stand Against Prediabetes campaign aiming for early detection, better management

26 Apr 2024 by

The ‘Stand Against Prediabetes; Don’t Sugarcoat It’ (SAPd) program was recently launched in Putrajaya.

Stand Against Prediabetes campaign aiming for early detection, better management

26 Apr 2024

SGLT2 inhibitors a promising gout medication in T2D

23 Apr 2024 by

The use of sodium-glucose cotransporter type 2 (SGLT2) inhibitors lowers the risk of incident gout or recurrent gout flares among patients with type 2 diabetes who are taking metformin, as shown in a study.

SGLT2 inhibitors a promising gout medication in T2D

23 Apr 2024

Hyperglycaemia, dyslipidemia up risk of diabetic kidney disease

23 Apr 2024

A recent study has identified six common metabolic profiles among patients with type 2 diabetes (T2D). In addition, severe hyperglycaemia and moderate dyslipidemia are associated with an increased risk of diabetic kidney disease (DKD).

Hyperglycaemia, dyslipidemia up risk of diabetic kidney disease

23 Apr 2024

A sock to detect diabetic, CV complications?

22 Apr 2024 by

A study presented at EHRA 2024 demonstrated the potential of a sock fitted with a ballistocardiogram (BCG) sensor to predict diabetic complications by identifying foot pressure distribution patterns, as well as to detect cardiovascular issues.

A sock to detect diabetic, CV complications?

22 Apr 2024

Do GLP1 receptor agonists increase thyroid cancer risk?

20 Apr 2024 by

Use of glucagon-like peptide 1 (GLP1) receptor agonists does not contribute to an elevated risk of thyroid cancer, as shown in a Scandinavian cohort study with a mean follow-up of nearly 4 years.

Do GLP1 receptor agonists increase thyroid cancer risk?

20 Apr 2024

Keeping blood sugar under control reduces CRC risk in people with diabetes

20 Apr 2024

For individuals with diabetes mellitus (DM), optimal glycaemic control may protect against the risk of developing colonic adenoma and colorectal cancer (CRC), as reported in a population-based cohort study.

Keeping blood sugar under control reduces CRC risk in people with diabetes

20 Apr 2024

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

18 Apr 2024

Patients using multiple insulin injections demonstrate no significant difference in changes to A1c, insulin requirements, or weight after a year of treatment with a sodium glucose transporter 2 (SGLT2) inhibitor or glucagon-like peptide 1 (GLP1) receptor agonist, as shown in a study.

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

18 Apr 2024

Vitamin D insufficiency in early pregnancy highly prevalent in SG

17 Apr 2024 by

A local study has raised concerns about a high rate of hypovitaminosis D in early pregnancy in Singapore.

Vitamin D insufficiency in early pregnancy highly prevalent in SG

17 Apr 2024

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

17 Apr 2024

For patients with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) cirrhosis, treatment with glucagon-like peptide-1 receptor agonists helps reduce the risk of hepatic decompensation, portal hypertension, hepatocellular carcinoma, and liver transplantation, according to a study.

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

17 Apr 2024

News & Updates

Filter by Specialty:

Specialty:

Original New Drug Application Approvals by US FDA (1-15 April 2024)

Original New Drug Application Approvals by US FDA (1-15 April 2024)

Stand Against Prediabetes campaign aiming for early detection, better management

Stand Against Prediabetes campaign aiming for early detection, better management

SGLT2 inhibitors a promising gout medication in T2D

SGLT2 inhibitors a promising gout medication in T2D

Hyperglycaemia, dyslipidemia up risk of diabetic kidney disease

Hyperglycaemia, dyslipidemia up risk of diabetic kidney disease

A sock to detect diabetic, CV complications?

A sock to detect diabetic, CV complications?

Do GLP1 receptor agonists increase thyroid cancer risk?

Do GLP1 receptor agonists increase thyroid cancer risk?

Keeping blood sugar under control reduces CRC risk in people with diabetes

Keeping blood sugar under control reduces CRC risk in people with diabetes

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

Vitamin D insufficiency in early pregnancy highly prevalent in SG

Vitamin D insufficiency in early pregnancy highly prevalent in SG

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD